Learn more about UC TechAlerts – Subscribe to categories and get notified of new UC technologies

Browse Category: Biotechnology > Health

Categories

[Search within category]

Anti-microbial, Immune-modulating, Naturally-derived Adjunctive Therapies

Researchers at the University of California, Davis have developed adjunctive therapies applicable to multiple types of infectious conditions. These therapies – derived from compounds found in natural herbs - also have potential prophylactic efficacy.

A Broadly Neutralizing Molecule Against Clostridium Difficile Toxin B

Researchers at UCI have developed a family of recombinant protein therapeutics against Clostridium difficile designed to provide broad-spectrum protection and neutralization against all isoforms of its main toxin, TcdB. These antitoxin molecules feature fragments of TcdB’s human receptors which compete for TcdB binding, significantly improving upon existing antibody therapeutics for Clostridium difficile infections.

Rapid Generation Of A Droplet Compound Library

The present invention features a device for rapidly formatting a chemical compound library into microfluidic droplets, addressing the challenge of interfacing between the macroscale and the microscale regimes of the production of reagent libraries of chemical compounds.

Delivery System For Transcatheter Valves

Researchers at UCI have developed a novel medical device for use in transcatheter heart valve replacement surgeries. The device provides physicians with more careful control of the catheter insertion, minimizing complications and adverse effects.

MicroRNA regulation of airway mucins for treatment of lung diseases

This invention describes a novel therapeutic microRNA target regulating mucus production for the management of symptoms caused by a range of lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and the common cold. Recently, a specific miRNA, along with its highly homologous family members, has been shown to be dysregulated in asthmatic subjects. To modulate the effect of these miRNAs, antagomirs (which target specific endogenous miRNAs and dampen their effect) or miRNA mimics can be administered via an inhaler, allowing for the regulation of mucus production. This invention is at the preclinical stage, and in vivo testing in a mouse model of asthma has shown that treatment with a specific miRNA antagomir results in a significant reduction of airway mucus production. While there are currently no effective therapies targeting mucus production in the airways, miRNAs are a promising new avenue for therapeutic intervention as they are fast-acting and reversible. 

Esophageal Deflection Device

Cardiac ablations are common medical treatments for people with atrial fibrillation (Afib). During the ablation procedure, a cardiac electrophysiologist will thermally ablate, or burn off, defective heart tissue with radiofrequency or cryoablation technology. The esophagus is often in close proximity to the left atrium. Since the left atrial tissue is approximately 2mm thin, the heat can transfer through it to the esophagus in contact and cause thermal damage / lesions on the esophagus.  In worst-case rare scenarios, an atrio-esophageal fistula, or hole between the esophagus and the heart, can occur which has a ~75% mortality rate.  It would be ideal to move the esophagus away from the heart before or during the ablation procedure preventing thermal damage.

Implantable Substance Delivery Devices

This invention describes a method for preparing an implantable device made from biocompatible polymers for sustained delivery of a substance within a body of human or an animal.

A Wearable Freestanding Electrochemical Sensing System

Researchers in the UCLA Department of Electrical and Computer Engineering have developed a strategy for high-fidelity, wearable biomarker data acquisition and sensor integration with consumer electronics.

A Thin Film Nitinol Neurovascular Covered Stent For Small Vessel Aneurysms

UCLA researchers in the Department of Pediatrics have developed a thin and flexible stent that can be implanted in small vessels in the neurovascular system. Normal 0 false false false EN-US ZH-CN X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;}

A Fully Integrated Stretchable Sensor Arrays for Wearable Sign Language Translation To Voice

UCLA researchers in the Department of Bioengineering have developed a novel machine learning assisted wearable sensor system for the direct translation of sign language into voice with high performance.

A Wireless Textile Based Sensor System for Self-Powered Personalized Health Care

UCLA researchers in the Department of Bioengineering have developed a textile-based sensor system (TS system) for wireless, wearable biomonitoring.

New And Integrated Method For Continuous Auditory Brain Stimulation

Various examples of delivering continuous auditory stimulation of various kinds (sometimes referred to by the term “entrainment”) have been proposed to modulate brainwaves for therapeutic effect. Current methods of delivering continuous auditory stimulation typically present noises (in the form of clicks, tones, pulses) embedded in music. By modulating the user’s existing audial environment to embed continuous auditory sound stimulation, this technology creates a more tolerable and user-friendly experience that enables prolonged therapeutic stimulation for such neurodegenerative disorders as Alzheimer’s, Parkinson’s and Chronic Traumatic Encephalopathy (CTE).

Virtual Reality For Anhedonia Program

UCLA researchers in the Department of Psychology have developed a behavioral training program for the improvement of anhedonia.

Method to Enhance the Effectiveness of HIV Vaccines

Researchers at the University of California, Davis have developed adjuvants that promotes the efficacy of HIV vaccines.

Composition and Methods of a Nuclease Chain Reaction for Nucleic Acid Detection

This invention leverages the nuclease activity of CRISPR proteins for the direct, sensitive detection of specific nucleic acid sequences. This all-in-one detection modality includes an internal Nuclease Chain Reaction (NCR), which possesses an amplifying, feed-forward loop to generate an exponential signal upon detection of a target nucleic acid.Cas13 or Cas12 enzymes can be programmed with a guide RNA that recognizes a desired target sequence, activating a non-specific RNase or DNase activity. This can be used to release a detectable label. On its own, this approach is inherently limited in sensitivity and current methods require an amplification of genetic material before CRISPR-base detection. 

Mediator-Free Electroenzymatic Sensing with Enhanced Sensitivity and Selectivity for Wearable Metabolite and Nutrient Monitoring Applications

UCLA researchers in the Department of Electrical and Computer Engineering have developed a wearable electroenzymatic sensor for non-invasive monitoring of metabolites and nutrients. The sensor has been successfully tested in human subjects to be highly sensitive and selective, making it ideal for monitoring and improving individual well-being.

Wearable Voltammetric Monitoring of Electroactive Drugs

UCLA researchers in the Department of Electrical and Computer Engineering have developed a voltammetric wearable device capable of monitoring electroactive drug circulation and abundance in biofluids. This non-invasive monitoring system can be used for electroactive drug therapy management, drug compliance/abuse monitoring, drug-drug interaction studies, and personalized dosing.

Novel Drug Delivery Platform

This invention is a novel method for synthetically designing protein carriers (enFoldin) for small molecules.  

Chimeric Cas9 Variants With Novel Engineered Enzymatic Activities

In this invention, the HNH domain of a Cas9 is replaced by a domain that could have diverse enzymatic activities. This invention enables engineering of Cas9 chimeras that possess novel, conformation-sensitive enzymatic activity to perform specific genome editing in vitro, in vivo, and ex vivo.Prior to this invention, all of the strategies to engineer Cas9 fusion proteins and provide Cas9 with non-natural enzymatic activity for genome manipulations were engineered by fusing specific domains to the N- or C-terminus of Cas9 via long and flexible linkers, or through domain insertion approach. The disadvantages of these synthetic Cas9 chimeras are that the attached domain is on the long flexible linker, and it is very dynamic. Thus, these fusions have a broad activity window and they are large, which makes it difficult to deliver them to the cells. 

Bioengineered RNA Molecules for Cancer Therapy

Researchers at the University of California, Davis have developed a method to use biologic RNA molecules for cancer research and therapy.

  • Go to Page: